Eric H. Bjerkholt
2017 - Sunesis Pharmaceuticals
In 2017, Eric H. Bjerkholt earned a total compensation of $322.5K as Former Executive Vice President, Corporate Development and Finance, Chief Financial Officer and Corporate Secretary at Sunesis Pharmaceuticals, a 63% decrease compared to previous year.
Compensation breakdown
| Salary | $137,301 |
|---|---|
| Other | $185,236 |
| Total | $322,537 |
Bjerkholt received $185.2K in other compensation, accounting for 57% of the total pay in 2017.
Bjerkholt also received $137.3K in salary.
Rankings
In 2017, Eric H. Bjerkholt's compensation ranked 13,164th out of 14,666 executives tracked by ExecPay. In other words, Bjerkholt earned more than 10.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 13,164 out of 14,666 | 10th |
Division Manufacturing | 5,186 out of 5,772 | 10th |
Major group Chemicals And Allied Products | 1,880 out of 2,075 | 9th |
Industry group Drugs | 1,567 out of 1,731 | 10th |
Industry Pharmaceutical Preparations | 1,213 out of 1,333 | 9th |
Source: SEC filing on April 25, 2018.
Bjerkholt's colleagues
We found two more compensation records of executives who worked with Eric H. Bjerkholt at Sunesis Pharmaceuticals in 2017.